v3.26.3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
Revenue $ 2,828 $ 2,267 $ 4,157 $ 800
Operating costs and expenses:        
Cost of revenue 1,758 1,938 2,728 514
Research and development 7,877 7,019 9,519 7,998
Selling, general and administrative 8,665 3,909 6,058 2,799
Grant income (964) (1,562) (1,673) (2,036)
Total operating costs and expenses 17,336 11,304 16,632 9,275
Loss from operations (14,508) (9,037) (12,475) (8,475)
Other expenses (income):        
Interest income (380) (329) (446) (88)
Finance leases interest expense 73 83 114 149
Other expense (income), net 17 19 (24)
Change in fair value of convertible notes     1,492
Loss before income tax expense (14,201) (8,808) (12,162) (10,004)
Income tax expense 126 37 61
Net loss (14,327) (8,808) (12,199) (10,065)
Other comprehensive income (loss):        
Foreign currency translation adjustment, net of taxes (18) 118 118 (63)
Total other comprehensive income (loss) (18) 118 118 (63)
Total comprehensive loss $ (14,345) $ (8,690) $ (12,081) $ (10,128)
Net loss per share attributable to common stockholders, basic $ (1.34) $ (0.83) $ (1.15) $ (0.95)
Net loss per share attributable to common stockholders, diluted $ (1.34) $ (0.83) $ (1.15) $ (0.95)
Weighted average shares used in computing net loss per share attributable to common stockholders, basic 10,731,360 10,627,932 10,638,595 10,575,252
Weighted average shares used in computing net loss per share attributable to common stockholders, diluted 10,731,360 10,627,932 10,638,595 10,575,252